Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1-Reference-Cited by-同舟云学术

Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Published:2012-07-29 Issue:9 Volume:13 Page:832-842
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Chiba Shigeki,Baghdadi Muhammad,Akiba Hisaya,Yoshiyama Hironori,Kinoshita Ichiro,Dosaka-Akita Hirotoshi,Fujioka Yoichiro,Ohba Yusuke,Gorman Jacob V,Colgan John D,Hirashima Mitsuomi,Uede Toshimitsu,Takaoka Akinori,Yagita Hideo,Jinushi Masahisa

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.2376.pdf

Reference50 articles.

1. Hanahan, D. & Weinberg, R.A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

2. Schreiber, R.D., Old, L.J. & Smyth, M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).

3. Bindea, G., Mlecnik, B., Fridman, W.H., Pages, F. & Galon, J. Natural immunity to cancer in humans. Curr. Opin. Immunol. 22, 215–222 (2010).

4. Dougan, M. & Dranoff, G. Immune therapy for cancer. Annu. Rev. Immunol. 27, 83–117 (2009).

5. Rabinovich, G.A., Gabrilovich, D. & Sotomayor, E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25, 267–296 (2007).

Cited by 669 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10

2. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

3. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09

4. TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3;Communications Biology;2024-09-05

5. Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09